Browsing HLS Student Papers by Title
Now showing items 101-120 of 498
-
A DOSE OF YOUR OWN MEDICINE? DRUG TESTING ON CHILDREN AND LABELING DRUGS FOR PEDIATRIC USE--ESSENTIAL NEEDS
(1997)Children are not just miniature adults; a child metabolizes and absorbs drugs differently than adults, making drug testing and labeling regarding pediatric use essential. This paper first addresses these needs in more ... -
Dr. Koch: A Cancer Quack?
(2006)This paper discusses the life and medical research of Dr. William F. Koch, a physiologist who claimed to have discovered a cure for cancer in the 20th century. Dr. Koch’s early education and research is ... -
Drafting organic Food Regulations: The Case for Incorporating Congressional Intent and Interest Group Commentary
(1999)The scope of the organic food debate has embroiled more constituents than simply consumers and producers of organic food. At each step along the way various interest groups such as small organic farmers, private organic ... -
Drug Reimportation: Prescription, Placebo, or Poison?
(2002)This paper examines drug reimportation as a means of reducing prescription drug prices paid by U.S. consumers. Specifically, this paper examines the provisions of the MEDS Act of 2000, which was passed by Congress right ... -
Drug Shortages: The Problem Of Inadequate Profits
(2014-03-18)Drug shortages are a growing problem in the United States. The scope and severity of drug shortages has caught the public eye and prodded the FDA into action. Among the potential causes of drug shortages are Medicare Part ... -
DRUG THERAPY AND PREGNANCY: UNKNOWN RISKS LEAD TO HARD CHOICES [REDACTED VERSION]
(2001)This paper is a proposal to improve the quality of information available to pregnant patients in selecting treatment options. By providing drug companies with extended grants of exclusivity, the FDA has the ability to ... -
DTC Prescription Drug Advertising: The History and Impact of FDA Regulation
(2002)This paper traces the history of direct-to-consumer (DTC) advertising for prescription drugs in the United States, beginning with the enactment of the Federal Food, Drug, and Cosmetics Act in 1938 and continuing through ... -
A DUE PROCESS FOR BIOETHICS
(2002)With the sequencing of the human genome, biomedical science has entered what is likely to be an era of remarkable progress. This progress will bring tremendous improvements to human life, but it also raises difficult ethical ... -
Due Process, Choice of Law, and the Prosecution of Foreign Nationals for Providing Material Support to Terrorist Organizations in Conflicts Abroad
(2015)In November 2012, a grand jury in the Eastern District of New York indicted Ali Yasin Ahmed, Mahdi Hashi, and Mohamed Yusuf under 18 U.S.C. § 2339B for knowingly and intentionally conspiring to provide material support and ... -
AN ECONOMIC ANALYSIS OF FOOD AND DRUG LAW: Selected Topics in FDA Enforcement
(1995)In this paper, I hope to introduce the world of Law & Economics to the world of FDA enforcement. By no means is this an effort to analyze every problem dealing with the subject of FDA enforcement. Similarly, the purpose ... -
An Edict from the Thought Police: Reconciling American and European Approaches to Geographical Designations
(1997)The United States is, relatively speaking, a young country, built by immigrants who tried to replicate the best of the world they left behind. The European Union is, strictly speaking, even younger than the U.S., but its ... -
Education or Promotion?: Industry-Sponsored Continuing Medical Education (CME) as a Center for the Core/Commercial Speech Debate
(2003)Because of its importance to determining drug usage, information has always been an important part of the regulation of prescription drugs. The Food and Drug Administration (FDA) and the pharmaceutical industry are in a ... -
THE EFFECT OF FDA'S POLICIES ON THE DECREASING EFFECTIVENESS OF ANTIBIOTICS
(1995)This paper will evaluate the effect that the Food and Drug Administration (FDA) has had on the drug resistance problem and will consider how the FDA could tailor its regulatory policies to better safeguard the effectiveness ... -
The Effect of Managed Care on the Pharmaceutical Industry
(1997)The pharmaceutical industry has transformed itself in response to the growth of managed care, which developed as a method to contain the costs of health care. Under the traditional fee-for-service system of practicing ... -
The Effects of False Claims Act Whistleblowers on the Pharmaceutical Industry
(2006)The whistleblower (or “qui tamâ€) provisions of the False Claims Act allow private citizens to bring suit on behalf of the government against individuals or corporations who have submitted ... -
Eliminating Earmarks: Why the Congressional Line Item Vote Can Succeed Where the Presidential Line Item Veto Failed
(2009-12-05)Congressional earmarking is an issue of growing concern in the United States. Although it currently accounts for a small percentage of federal expenditures, recent trends indicate that such pork-barrel spending will soon ... -
The Elusive Silver Bullet: FDA Failures, Rejected New Drug Applications, and the Search for an Obesity Cure
(2011)Over the past forty-five years, America has fallen victim to an obesity epidemic, affecting more than thirty percent of American adults. If the incidence of obesity continues at current rates, an estimated forty-percent ... -
The Emerging Field of Race-Based Genetic Research: Can We Trust It?
(2006)In June of 2005, the Food and Drug Administration approved a heart disease drug named BiDil exclusively for African Americans, provoking a fiery debate among medical researchers, sociologists, and legal scholars. On the ... -
Empowering Women: A Feminist Argument for Over-the-Counter Sale of Oral Contraceptives
(2005)The oral contraceptive pill, having been on the market for 45 years, should be sold over-the-counter. There is no longer any valid reason for FDA to maintain the prescription status of the drug. First, numerous studies ... -
English is not Enough: The Language of Food and Drug Labels
(2002)Food and drug labels must respond to the needs of the increasing linguistic minority population in the United States. Currently, the FDA only requires that food and drug labels be in English. Due to the growing segment of ...